Financial statements Sn Biotech Technologies Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of SN BIOTECH TECHNOLOGIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 235 597,60 | 189 238,37 | 1 918 568,77 | 1 671 736,39 | 1 685 039,03 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 235 597,60 | 189 238,37 | 1 918 568,77 | 1 671 736,39 | 1 685 039,03 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 235 597,60 | 189 238,37 | 1 918 568,77 | 1 671 736,39 | 1 685 039,03 |
| A. Equity | 216 072,49 | 141 609,88 | 1 477 205,73 | 1 574 591,82 | 1 678 591,03 |
| B. Liabilities and provisions for liabilities | 19 525,11 | 47 628,49 | 441 363,04 | 97 144,57 | 6 448,00 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.